Suchergebnisse - (Person:"Moghimi, Setareh")

PubPharm (6)

1

Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents : A contemporary perspective of SAR and molecular docking studies

enthalten in: European journal of medicinal chemistry | 2023

von Moradi, M. | Mousavi, A. | Emamgholipour, Z. | +6

2

Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors : Design, synthesis, bioactivity evaluation, and in silico studies

enthalten in: Bioorganic chemistry | 2023

von Hasanvand, Z. | Oghabi Bakhshaiesh, T. | Peytam, F. | +15

3

Thienopyrimidine-based agents bearing diphenylurea : Design, synthesis, and evaluation of antiproliferative and antiangiogenic activity

enthalten in: Archiv der Pharmazie | 2023

von Mohammadian, E. | Oghabi Bakhshaiesh, T. | Jouyban, A. | +10

4

Synthesis of novel 2-acetamide-5-phenylthio-1,3,4-thiadiazole-containing phenyl urea derivatives as potential VEGFR-2 inhibitors

enthalten in: Archiv der Pharmazie | 2022

von Toolabi, M. | Safari, F. | Ayati, A. | +6

5

Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy

enthalten in: European journal of medicinal chemistry | 2021

von Ayati, A. | Moghimi, S. | Toolabi, M. | +1

6

A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy

enthalten in: Bioorganic chemistry | 2020

von Ayati, A. | Moghimi, S. | Salarinejad, S. | +3

1
[1]